Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results. Brastianos PK, Kim AE, Giobbie-Hurder A, Lee EQ, et al. Nat Med 2023;29:1728-1737.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brastianos PK, Kim AE, Giobbie-Hurder A, Lee EQ, et al. Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results. Nat Med 2023;29:1728-1737.
PMID: 37268724